PTGX · Company research
Protagonist Therapeutics, Inc (PTGX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 138.69 | $10,114,238,646.84 | 9694160646.84 | 62.2008733624454148 | — | — | 47.3790310192762619 | 12.0186831176065869 | 46.2082136969353635 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.